Abstract

CARDENAS RAMON, Itsel; AGUILA SETIEN, Sonia  and  OTERO IGLESIAS, Jacinta. Parenteral maternal hydrotherapy:. Rev Cubana Obstet Ginecol [online]. 2009, vol.35, n.3, pp. 0-0. ISSN 1561-3062.

Oligohydramnios or oligoamnios is the amniotic fluid decrease to pathological figures with a high amniotic fluid rate (AFR) less or similar to 5 cm, and it is a fetal high risk, and secondarily maternal. OBJECTIVE: To demonstrate through a controlled clinical assay the effectiveness of parenteral maternal hydrotherapy (PMH) in isolated oligoamnios, in increase of AFR, and consecutively its repercussion on those perinatal results. METHODS: We made a controlled clinical assay to assess effectiveness of PHM in pregnants with isolated oligoamnios of 28 weeks or more of pregnancy in Gynecology and Obstetrics Teaching Hospital of Guanabacoa municipality from January 1, 2000 to December 31, 2004. Sample included 141 isolated oligoamnios and it was divided in two groups: study group with 56 patients and control-group with 85 patients. In study group, we administered PHM with 2000 mL of 0,9% isotopic saline solution, and in control-group there was an expectant behavior RESULTS: Isolated aligoamnios is more frequent in term pregnancy. Administration of PHM increases AFR in 43% (study group), and only in 22% of cases from control- group. Likewise, it was possible to increase gestational age in two weeks from diagnosis. In study group, transpelvic pregnancy; main cause of cesarean section was the acute fetal suffering in both groups, mainly in the control one. In study group there were not newborns presenting with neither respiratory syndrome nor congenital bronchopneumonia. CONCLUSIONS: PMH looks to be effective in management o isolated oligoamnios, decreasing perinatal morbidity and mortality, and secondarily, maternal wellbeing.

Keywords : Isolated oligohydramnios; parenteral maternal hydrotherapy.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )